# Endocannabinoid System & Adolescent Health: 15-Year REAL 2.0 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/15-year-adolescent-health-research-endocannabinoid-system/ > **Published:** 2026-03-12T13:01:21-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:08:42-04:00 > **Clinical Summary:** Explore 15-year adolescent health research on the endocannabinoid system revealing links between early risk factors and later mental health outcomes. --- #### Clinical Takeaway A 15-year Canadian cohort study tracked adolescents into early adulthood to examine how early risk factors like body image concerns and disordered eating contribute to later eating disorders, mental health conditions, and substance use problems. The study highlights that psychosocial vulnerabilities identified in adolescence can have lasting effects on multiple health outcomes simultaneously. Clinicians should consider early screening for body image and disordered eating as part of routine adolescent care to help prevent downstream multimorbid conditions. ### #6 Research on Eating and Adolescent Lifestyle (REAL) 2.0: 15-year follow-up study of eating disorders and weight-related trajectories, mental health and substance use health from early adolescence to early adulthood-a Canadian cohort profile. **Citation:** Obeid Nicole et al. *Research on Eating and Adolescent Lifestyle (REAL) 2.0: 15-year follow-up study of eating disorders and weight-related trajectories, mental health and substance use health from early adolescence to early adulthood-a Canadian cohort profile.* BMJ open. 2026. PMID: 41526025. **Study type:** Journal Article  |  **Topic area:** Pediatrics  |  **CED Score:** 12 Design: 0 Journal: 3 N: 4 Recency: 3 Pop: 3 Human: 1 Risk: -2 Why This Matters This 15-year longitudinal study provides critical evidence on how adolescent psychosocial risk factors, particularly disordered eating and body image disturbance, predict the development of eating disorders, weight-related conditions, and comorbid mental health and substance use disorders in young adulthood. Understanding these long-term trajectories enables clinicians to identify high-risk adolescents who require early intervention to prevent progression to severe, costly multimorbid conditions. The Canadian cohort data addresses a significant knowledge gap in how developmental eating and weight concerns evolve into adult psychopathology, informing prevention and treatment strategies for this vulnerable population. **Quality Gate Alerts:** - Preclinical only **Methodological Considerations:** - Cross-sectional design — causal inference not possible **Abstract:** PURPOSE: Few studies have examined how psychosocial risk and protective factors in adolescence shape mental health outcomes and other multimorbid conditions in adulthood, particularly among Canadian youth. The Research on Eating and Adolescent Lifestyle (REAL) 2.0 study was a 15-year follow-up cohort study designed to investigate how early etiological factors, including body image and disordered eating symptoms in adolescence, contribute to the development of eating, weight-related concerns, mental health and substance use health problems in early adulthood. In this paper, we describe the REAL 2.0 cohort’s demographic and clinical characteristics alongside an overview of the study procedures, laying the groundwork for collaboration on future learnings with this unique data. PARTICIPANTS: The cross-sectional REAL study initially surveyed middle and high school students from 2004 to 2010 (n=3043) across 43 schools in the Ottawa, Canada region. Of those, respondents in grade 7 or 9 (n=1197 from 25 of the 43 original schools) were asked to participate in a longitudinal arm of the study that consisted of yearly follow-ups. From the longitudinal cohort, there were 278 participants (29.1% male; Mage=28.6) from those who consented to be re-contacted (n=912), who completed the REAL 2.0 survey electronically (30.4%), providing comprehensive data on demographic, clinical, eating and weight-related behaviour, psychological, social, environmental and substance use health factors in adulthood. FINDINGS TO DATE: 9.4% of REAL 2.0 participants met DSM-5 criteria for an eating disorder, while 17.6% met criteria for disordered eating. Moderate to severe anxiety was reported by 28% of participants, while 21.6% experienced moderate to severe depressive symptoms. Regarding substance use, 16.9% engaged in hazardous drinking, 16.9% used cannabis daily or almost daily, and 4.3% reported daily tobacco use. FUTURE PLANS: REAL 2.0 has the potential to answer multiple research questions about s Clinical Perspective While the REAL 2.0 study provides valuable longitudinal data on how adolescent eating behaviors and body image concerns track into adulthood, clinicians should note that this cohort profile does not yet present cannabis-specific outcomes or mechanistic data linking cannabis use to the eating or mental health trajectories being examined. The study’s Canadian context and 15-year follow-up period offer meaningful insights into natural history, but without detailed substance use subanalyses or temporality data, we cannot infer whether cannabis use represents a risk factor, consequence, or confounding variable in the eating disorder and mental health pathways described. Of particular relevance to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) practitioners, adolescent substance use patterns often cluster with disordered eating and mood symptoms, yet distinguishing independent effects requires careful statistical adjustment for comorbid psychopathology and sociodemographic factors that the abstract does not detail. When counseling young patients about cannabis use in the context of body image concerns or emerging eating pathology, practitioners should await publication of the full results and  |   |  Further Reading Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 12, 2026](https://cedclinic.com/cannabis-regulatory-updates-march-2026/) CED Clinic Blog[Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years](https://cedclinic.com/cannabis-beverage-substitution-alcohol-new-york-five-years/) Research Digest[AM Policy Update: March 11, 2026](https://cedclinic.com/dea-rescheduling-marijuana-march-11-2026/) [View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/41526025/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12815037/)[DOI ↗](https://doi.org/10.1136/bmjopen-2025-103434) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Endocannabinoid System Research: Cannabis & Adolescent Health](https://cedclinic.com/adolescent-cannabis-mental-health-research/) Explore comprehensive research on the endocannabinoid system's role in [adolescent health](https://cedclinic.com/adolescent-cannabis-use-sexual-behavior-study/) and cannabis use. [Read More](https://cedclinic.com/adolescent-cannabis-mental-health-research/) [Endocannabinoid System Clinical Research: Eating Disorders](https://cedclinic.com/endocannabinoid-system-adolescent-eating-disorder-research/) Detailed [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) on the endocannabinoid system's impact on adolescent eating disorders. [Explore Study](https://cedclinic.com/endocannabinoid-system-adolescent-eating-disorder-research/) [Endocannabinoid System & Adolescent Health: Key Research](https://cedclinic.com/endocannabinoid-system-adolescent-health-clinical-evidence/) Key clinical evidence linking the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) with [adolescent health](https://cedclinic.com/adolescent-cannabis-use-sexual-behavior-study/) outcomes. [Learn More](https://cedclinic.com/endocannabinoid-system-adolescent-health-clinical-evidence/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Endocannabinoid%20System%20%26%20Adolescent%20Health%3A%2015-Year%20REAL%202.0&url=https%3A%2F%2Fcedclinic.com%2F15-year-adolescent-health-research-endocannabinoid-system%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F15-year-adolescent-health-research-endocannabinoid-system%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Endocannabinoid%20System%20%26%20Adolescent%20Health%3A%2015-Year%20REAL%202.0%20https%3A%2F%2Fcedclinic.com%2F15-year-adolescent-health-research-endocannabinoid-system%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).